OBJECTIVE: To evaluate "need-specific treatment" of first episode schizophrenia syndrome patients. METHOD: Sixty-one consecutive first episode schizophrenia syndrome patients were followed over 3 years. They were compared with a Historical "treatment as usual" group (n = 41) and a Prospective group from a high quality social and biological psychiatry centre (n = 25). RESULTS: Symptomatic and functional outcome was significantly better compared with the Historical group and equal with the Prospective group. During the first year, the direct costs for in- and out-patient care per patient in the Parachute project were less than half of those in the Prospective group. CONCLUSION: The study confirms the feasibility, clinically and economically, with a large scale application of "need-specific treatments" for first episode psychotic patients.
OBJECTIVE: To evaluate "need-specific treatment" of first episode schizophrenia syndromepatients. METHOD: Sixty-one consecutive first episode schizophrenia syndromepatients were followed over 3 years. They were compared with a Historical "treatment as usual" group (n = 41) and a Prospective group from a high quality social and biological psychiatry centre (n = 25). RESULTS: Symptomatic and functional outcome was significantly better compared with the Historical group and equal with the Prospective group. During the first year, the direct costs for in- and out-patient care per patient in the Parachute project were less than half of those in the Prospective group. CONCLUSION: The study confirms the feasibility, clinically and economically, with a large scale application of "need-specific treatments" for first episode psychoticpatients.
Authors: Jacek Hochwälder; Maria Mattsson; Ragnhild Holmqvist; Johan Cullberg; Bent Rosenbaum Journal: Qual Life Res Date: 2012-05-15 Impact factor: 4.147
Authors: Vinod H Srihari; Nicholas J K Breitborde; Jessica Pollard; Cenk Tek; Leslie Hyman; Linda K Frisman; Thomas H McGlashan; Selby Jacobs; Scott W Woods Journal: Psychiatr Serv Date: 2009-11 Impact factor: 3.084
Authors: Robert Rosenheck; Douglas Leslie; Kyaw Sint; Haiqun Lin; Delbert G Robinson; Nina R Schooler; Kim T Mueser; David L Penn; Jean Addington; Mary F Brunette; Christoph U Correll; Sue E Estroff; Patricia Marcy; James Robinson; Joanne Severe; Agnes Rupp; Michael Schoenbaum; John M Kane Journal: Schizophr Bull Date: 2016-01-31 Impact factor: 9.306